Market Overview

Why Verrica Pharmaceuticals Stock Is Trading Lower Today


Verrica Pharmaceuticals (NASDAQ: VRCA) shares are trading lower on Tuesday.

The company received a letter from the FDA regarding its VP-102 NDA indicating there are deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.

Verrica Pharmaceuticals is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Verrica Pharmaceuticals shares were trading down 25.8% at $10.44 at the time of publication Tuesday. The stock has a 52-week high of $18.67 and a 52-week low of $6.79.


Related Articles (VRCA)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at